SpectraScience, Inc. (SCIE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 12, 2025

SpectraScience Company Description

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally.

It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer.

The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body.

The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992.

SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

SpectraScience, Inc.
Country United States
Founded 1983
Industry Medical Devices
Sector Healthcare
Employees 7

Contact Details

Address:
11568 Sorrento Valley Road
San Diego, Minnesota 92121
United States
Phone 858 847 0200
Website spectrascience.com

Stock Details

Ticker Symbol SCIE
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US84760E3018
SIC Code 3845

Key Executives

Name Position
Lowell W. Giffhorn Chief Financial Officer and Secretary